1 These two cases occur in the context of a changing epidemiology GSK-3 inhibitor of cutaneous leishmaniasis in Morocco itself, with an increasing distribution of disease throughout the country and the emergence of three coexisting species: Leishmania major, Leishmania tropica, and Leishmania infantum.2,3 This change is significant in a country
previously regarded as relatively low risk for travelers from the perspective of vector-borne infections (such as malaria and dengue). Returned travelers could have a valuable role as sentinels for changing prevalence of neglected diseases in endemic visited countries, particularly if local disease monitoring is suboptimal. MAPK Inhibitor Library price These data become increasingly helpful when surveillance of infected travelers is undertaken in a systematic manner.4 Sodium stibogluconate and fluconazole were used to treat these two cases, reflecting the scant durable evidence available to guide therapy of OWCL, particularly in returned travelers. Pentavalent antimonial drugs (sodium stibogluconate or meglumine antimonate) are the traditionally accepted first-line agents.5,6 Although these agents can be injected intralesionally, patients with large or multiple lesions require parenteral administration, usually for 21 days, with attending
toxicities and demands on health care contact. Evidence for fluconazole in cutaneous L major infection is mixed.7 Miltefosine has recently emerged as an agent for the treatment of leishmaniasis, with the significant advantages of good oral bioavailability and tolerability. As yet, the evidence for miltefosine in OWCL is limited to a number of case reports and a single randomized, controlled trial for OWCL due to L major in
Iran.8,9 Efficacy varies between species. Identification of the Leishmania species infecting returned travelers by PCR is extremely useful. Species identification facilitates epidemiological study, which is particularly important if such investigation is difficult in the endemic country due to political instability or a lack of resources. It also contributes significantly to selection of the most appropriate treatment.8 With both cases presented here, the diagnosis of leishmaniasis was not considered mafosfamide prior to the histological report, after the biopsy specimens were placed in formalin, thus reducing the yield of PCR techniques. This reinforces the importance of raising awareness of this neglected disease in nonendemic countries. The authors state they have no conflicts of interest to declare. “
“Background. There is an increasing number of imported cases of schistosomiasis in Europe, but there are only few studies on the efficacy of praziquantel for the treatment of schistosomiasis in non-endemic settings. Methods.